Skip to content

Effect of Left Atrial Ablation on Left Atrial Appendage Emptying Flow Velocity

Differential Effect of Radiofrequency and Cryoballoon Ablation on Left Atrial Appendage Emptying Flow Velocity

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02801175
Acronym
ABLAA-FV
Enrollment
40
Registered
2016-06-15
Start date
2016-05-31
Completion date
2017-03-31
Last updated
2016-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

Consecutive patients with paroxysmal AFib scheduled to undergo pulmonary vein isolation either with radiofrequency (RF) or cryoballoon will be included. Left atrial appendage emptying flow velocity (LAA-EFV) will be measured with transesophageal echocardiography (TEE) immediately before and following left atrial ablation (1 month post). The change in LAA-EFV will be compared between the two groups (RF versus Cryo).

Interventions

PROCEDUREPulmonary vein isolation

Sponsors

G.Gennimatas General Hospital
CollaboratorOTHER
National and Kapodistrian University of Athens
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

Paroxysmal atrial fibrillation, no absolute contraindication for anticoagulation

Exclusion criteria

Previous cardiac surgery Previous left atrial ablation History of cerebrovascular event Presence of LAA thrombus Inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
LAA-EFV1 monthLeft atrial appendage emptying flow velocity

Secondary

MeasureTime frameDescription
LAA-EFV3 monthsLeft atrial appendage emptying flow velocity

Countries

Greece

Contacts

Primary ContactSpyridon Deftereos, MD
spdeftereos@med.uoa.gr2105832352

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026